Diligence memo · auto-generated · as of July 2, 2026
Lincoln Park Biosciences, LLC
Lincoln Park Biosciences, LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Lincoln Park Biosciences, LLC operates in Manufacturing, based in SCOTTSDALE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Lincoln Park Biosciences, LLC has raised $400K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $400K on 2022-06-20.
Most recent recorded round closed around 2022-06-20.
Valuation (modeled)modeled
Provath models Lincoln Park Biosciences, LLC at approximately $3.0M (range $272K–$19M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.62× the median modeled value of Pre-Seed Manufacturing companies in 2022–2024 (161 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.0 yr ago; this sector typically re-raises about every 12 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 19% of Manufacturing peers (3257 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: LPG Technology Group, North Iron Mason Dynamics LLC, Ares Sportswear Ltd., Atlas Diversified Products Corp., Pawket Treats, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.